Blocking Histone Deacetylase Activity as a Novel Target for Epithelial Barrier Defects in Allergic Rhinitis

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.263
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Histone Deacetylase 8 as a Novel Therapeutic Target in Oral Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Histamine and T Helper Cytokine Driven Epithelial Barrier Dysfunction in Allergic Rhinitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

P062 Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Rheumatoid Arthritis

2019English

P116 Histone Deacetylase 1: A Novel Therapeutic Target for Patients With Rheumatoid Arthritis

2018English

Carbocisteine Improves Histone Deacetylase 2 Deacetylation Activity via Regulating Sumoylation of Histone Deacetylase 2 in Human Tracheobronchial Epithelial Cells

Frontiers in Pharmacology
Pharmacology
2019English

Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas

Laryngoscope
Otorhinolaryngology
2011English

Multi-Strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis

Journal of Contemporary Immunology
2014English

A Functional Genetic Screen Identifies Retinoic Acid Signaling as a Target of Histone Deacetylase Inhibitors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Allergic Rhinitis as a Risk Factor for Habitual Snoring in Children

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy